chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the vaccine in my upper arm at 8:30 a.m. on Wednesday, December 6th, as part of a flu shot clinic that was being offered to employees.  About 3 hours later, at 11:30 a.m., I was sitting at my desk working when my hands began to sweat and were cold, my heart began to race, I felt light-headed and thought I was going to faint.  I immediately headed over to the Student Health and Wellness center and told them I thought I was having an allergic reaction to the flu vaccine, which I had never had previously.  When I arrived my temperature was elevated, at about 99 degrees F, and my pulse was 130 beats per minute.  They took me in the back and my symptoms worsened.  I still felt very faint and dizzy, and was experiences waves of extreme nausea and extreme anxiety.  My hands were also still cold and sweating.  The health care workers weren't convinced that I was reacting to the flu shot, because my symptoms weren't typical of an allergic reaction.  They did a glucose test and a thyroid level test.  The glucose test came back immediately and was normal, the thyroid test came back normal the following day as well.  My symptoms worsened as I waited in the health center for about an hour and a half.  My throat then began to swell and my face became tingly.  The doctor then prescribed me an anti-histamine (Zyrtec 10mg) and my symptoms gradually lessened over the next hour and a quarter while they monitored me.  After I felt that my symptoms were under control I went home and slept for quite awhile as I was very tired.  My throat was still a little swollen for a couple hours afterward, but I didn't experience any other symptoms after the anti-histamine took effect.  My arm was sore for a couple days following the shot, but that has subsided as well.  It should be noted that there was no visible irritation at the site of injection at any point after my shot, however it was swollen and hard.
Swelling at the injection site; Burning at the injection site; Posible dermal injection; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE DYSAESTHESIA (Burning at the injection site) and VACCINATION SITE ERYTHEMA (Posible dermal injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE DYSAESTHESIA (Burning at the injection site) and VACCINATION SITE ERYTHEMA (Posible dermal injection). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE DYSAESTHESIA (Burning at the injection site) and VACCINATION SITE ERYTHEMA (Posible dermal injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant and treatment medications were not provided.
Coldness/ tingling/ numbness sensation on entire left side of gastrocnemius. Can still flex/ stretch/ walk. No signs of rash
she felt "very bad, weak, tired; muscle pain on her back; she felt "very bad, weak, tired; she felt "very bad, weak, tired; congested like sinusitis; nausea; dizzy; This is a spontaneous report from a contactable consumer or other non hcp. A 70-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: unknown; Expiration Date: unknown), dose 1 via an unspecified route of administration on 07Feb2021 as single dose for covid-19 immunization.  Medical history included covid-19 from an unknown date. She had COVID-19 "three or four" weeks before the vaccine. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced she felt "very bad, weak, tired (fatigue), muscle pain on her back, congested like sinusitis, nausea, dizzy. The outcome of the events very bad, weak, tired, was unknown; muscle pain on her back was recovered; congested like sinusitis, nausea, dizzy was not recovered.  Follow-up attempts are completed. No further information is expected.
Headache, Myalgia, Arthralgia, Fever, Tachycardia, Localized pain; chills, fatigue
swelling redness & warmness on her upper arm; swelling redness & warmness on her upper arm; swelling redness & warmness on her upper arm; tiredness low grade fever, chills and body aches; tiredness low grade fever, chills and body aches; tiredness low grade fever, chills and body aches; tiredness low grade fever, chills and body aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness low grade fever, chills and body aches), PYREXIA (tiredness low grade fever, chills and body aches), CHILLS (tiredness low grade fever, chills and body aches), MYALGIA (tiredness low grade fever, chills and body aches) and PERIPHERAL SWELLING (swelling redness & warmness on her upper arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017b21a and 023m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tiredness, Fever, Chills, Pain (body aches), Swelling and Redness. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced FATIGUE (tiredness low grade fever, chills and body aches), PYREXIA (tiredness low grade fever, chills and body aches), CHILLS (tiredness low grade fever, chills and body aches) and MYALGIA (tiredness low grade fever, chills and body aches). On 29-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling redness & warmness on her upper arm), ERYTHEMA (swelling redness & warmness on her upper arm) and FEELING HOT (swelling redness & warmness on her upper arm). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, FATIGUE (tiredness low grade fever, chills and body aches), PYREXIA (tiredness low grade fever, chills and body aches), CHILLS (tiredness low grade fever, chills and body aches) and MYALGIA (tiredness low grade fever, chills and body aches) had resolved and PERIPHERAL SWELLING (swelling redness & warmness on her upper arm), ERYTHEMA (swelling redness & warmness on her upper arm) and FEELING HOT (swelling redness & warmness on her upper arm) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Breakthrough case admission after 5 vaccines Moderna 3/1/21 Lot# 010A21A;  Moderna 3/29/21 Lot# 018B21A;  Moderna 10/25/21 Lot# 02D621A;  Moderna 3/31/22 Lot# 002M21A;  Moderna 9/3/22 Lot# AS7164B
Roughly 24 hrs later, extreme fatigue, severe headache, severe joint pain., nausea, fever.  Symptoms lasted roughly 17 additional hrs.
Covid-19 symptoms. OCt 12th. Fatigue, body aches fever, congestion, lose of taste and smell, went to see dr on Oct 13 was tested for covid and flu, negative for both treatment was fever, lots of liquids and rest. Lasted about 14 days.
left on the counter, temperature excursion; This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received Hepatitis B vaccine (batch number 97kt7, expiry date unknown) and (batch number f22ez, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Hepatitis B vaccine. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional Information: GSK Receipt Date: 21-JUN-2022 Reporter's comments: The reporter stated that 4 boxes were left on the counter in their labor and delivery area. The pharmacy sent those up at 11 AM and they were brought back down to pharmacy at room temperature at 3 PM. The reporter stated that he/she had separated those boxes from the rest of the vaccines and put back in refrigeration and enquired of the next steps. 3 boxes had LOT number 97kt7 and 1 box had LOT number f22ez. The consent to follow up was granted. Additional Supportive Information: The reporter stated that the boxes were left at the counter and then later kept at room temperature, which led to incorrect storage of drug.
Initial unsolicited report received from the literature on 01 June 2016. This case is linked to cases 2016SA108584, 2016SA108560, and 2016SA108575 (same literature). The following is verbatim from the article: Background. Many adult immunization schedules recommend that tetanus and diphtheria vaccination be performed every 10 years. In light of current epidemiological trends of disease incidence and rates of vaccine-associated adverse events, the 10-year revaccination schedule has come into question. Methods. We performed cross-sectional analysis of serum antibody titers in 546 adult subjects stratified by age or sex. All serological results were converted to international units after calibration with international serum standards. Results. Approximately 97 percent of the population was seropositive to tetanus and diphtheria as defined by a protective serum antibody titer of .0.01 IU/mL. Mean antibody titers were 3.6 and 0.35 IU/mL against tetanus and diphtheria, respectively. Antibody responses to tetanus declined with an estimated half-life of 14 years (95 percent confidence interval, 11.17 years), whereas antibody responses to diphtheria were more long-lived and declined with an estimated half-life of 27 years (18.51 years). Mathematical models combining antibody magnitude and duration predict that 95 percent of the population will remain protected against tetanus and diphtheria for 30 years without requiring further booster vaccination. Conclusions. These studies demonstrate that durable levels of protective antitoxin immunity exist in the majority of vaccinated individuals. Together, this suggests that it may no longer be necessary to administer booster vaccinations every 10 years and that the current adult vaccination schedule for tetanus and diphtheria should be revisited. This case involves an 86-year old patient (gender not reported) who was vaccinated with a dose of TDAP (lot number, expiry date, dose, dose series, route and site of administration: not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unknown date, unspecified timeframe after vaccination, the patient lacked immunity to both toxins (diphtheria and Tetanus). A serum antibody titers was performed (results not provided). Other laboratory data and corrective treatment was not reported. The outcome of the event was not reported. Documents held by sender: none.
Physician reports being paged on Sat. 2/25/12 by patient with swelling, redness and warmth at site of injection. On 2/27/12 patient updates office that symptoms have resolved.
Inadvertent temperature excursion, vaccine stored in freezer beyond allowable two-week excursion protocol per Pfizer, no concern for any other adverse events, recommended repeat dose
Severe chills. Lasting 4-6 hrs - bed rest. Numerous blankets. Headache - soreness, muscle aches of upper back.
lymph node in right armpit swelled up - between the size of a golf ball and a tennis ball,  and was very tender to the touch
had medicinal taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162B2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "had medicinal taste".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sharp pain in the right supraclavicular area radiating to the back (suprascapular) area. Seems to be temporarily controlled with a combination of acetaminophen and ibuprofen but resumes after the medication wears off.
Hour long tantrum from time of vaccine until long after arriving home, neurological issues including sensory issues and evolving sensory and possible Sensory Processing Disorder or ADHD became increasingly worse within days of vaccine.
Started with a fever Tuesday following her shots. No other symptoms. Fever was as high 104.2. Took her to emergency Department twice. They put it off as febrile illness. Monday almost a week and a half after shots she started with a blistery rash all over belly and back. And under arms. Still has fever. Only wants to sleep. Drinks a little. Completely not herself.
Initial report received on 07 November 2006 from a health care professional.  A 74-year-old patient (gender not provided), with a past medical history of hypothyroidism, had received an intra-muscular injection os FLUZONE SV '2006-'2007 USP, lot number U2242AA, on 23 October 2006. The route of administration was not reported.  The patient was taking Lipitor, Coumadin and Synthyroid at the time of vaccination.  Two days post-immunization, on 25 October 2006, the patient developed symptoms (symptoms were not reported).  At an unspecified amount of time later, the patient was evaluated by a physician and diagnosed with mesenteric adenitis.  The patient required hospitalization (dates were not reported).  Diagnostic tests revealed an increased liver function test, and an increased INR level.  At the time of this report, the patient had not recovered.
Intermittent tachycardia and shortness of breath, L sided chest pain and upper abdominal pain.  Initially symptoms were more constant, was improving to intermittent by 6/21/21.  The shortness of breath occurred without exertion.
At 1450 on 8/12/2013 the shots (MMR - Varicella - IPV - PPD) was given about 10 min later eye was swollen (angioedema) nasal congestion, cough, hives on face - neck epinephrine 1/1000 0.08ml was given at 1508 in 10-15 min all symptoms getting better at 1600 Pt fine D/C home.
Started suddenly having allergic reactions to foods containing milk. I would have itchy mouth, swollen tongue, mouth sores, tingling lips, throat tightness, rapid heart rate, stomach pain and diarrhea. The allergic reactions started shortly after my first dose of the vaccine.  I treated the reactions with Benadryl. I now have to carry an epinephrine injector with me at all times.
Infanrix was administered to a 7-year-old patient.; Infanrix was administered but planned vaccine was Tdap; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa (Infanrix) (batch number 7HM5J, expiry date 13-SEP-2024) for prophylaxis.   On 06-OCT-2023, the patient received Infanrix. On 06-OCT-2023, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Infanrix was administered to a 7-year-old patient.) and wrong vaccine administered (Verbatim: Infanrix was administered but planned vaccine was Tdap).  The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 12-OCT-2023 A nurse reported that Infanrix was administered to a 7-year-old patient but nurse states planned vaccine to be given was Tdap which led to Wrong vaccine administered and Inappropriate age at vaccine administration. The reporter consented to follow up.
L thigh large area of redness, heat and swelling - patient seen in ER and thought to have cellulitis but diagnosis of allergic localized reaction much more likely. Patient admitted for IV antibiotics and discharged home post 1 day with oral antibiotics.
This case was reported by a consumer and described the occurrence of allergic reaction in an elderly subject of unspecified gender who was vaccinated with Flulaval (GlaxoSmithKline) for prophylaxis.  A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of Flulaval (unknown).  At an unknown time after vaccination with Flulaval, the subject experienced allergic reaction.  At the time of reporting the outcome of the event was unspecified.
I woke up feeling sick with headache and pain in abdomen, went to bathroom and sat down, I was burning up and perspiration was dripping down my body, i felt like i might throw up and that was the last though until I came to on the floor of our walk in shower.  It took me a while to orient myself and get up and sat down again on toilet still with pain in head and disoriented. next thing i know i am coming to wedged between the toilet tank and the vanity.  I managed to get back on the toilet and sat there wondering what was happening to me.  I could tell i was getting better so i just sat there a while longer until i though my legs would hold me so i could get back to the bed.  I laid in bed the rest of the night unable to sleep with headache and shivering with being cold even under my blankets. I stayed in bed Saturday then called the doctor first thing Monday morning. I got in to see her at 10:30 Monday morning.  She ordered a full blood panel and urinalysis and heart monitor for 48 hours.  The blood panel and urinalysis reports are all ok.  Have not received report yet from the heart monitor.  Doc said I cannot take the second shot.
Left, non-dominant arm in which he received the dose began hurting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left, non-dominant arm in which he received the dose began hurting) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anxiety. Previously administered products included for Headache: ASPIRIN [ACETYLSALICYLIC ACID].    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (Left, non-dominant arm in which he received the dose began hurting). On 11-Feb-2021, VACCINATION SITE PAIN (Left, non-dominant arm in which he received the dose began hurting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD-2021-040327 (Patient Link).
expired Infanrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 1-year-old male patient who received DTPa (Infanrix) (batch number 49TM3, expiry date 28th May 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th June 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 8th June 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 02-Aug-2022 Reporter's comment: A nurse reported that a patient received an expired dose of Infanrix. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Infanrix, which led to expired vaccine used.
EMS reports patient was walking this evening 01/28/2022 when his feet slipped out from under him and he fell. His family notes that they were with him but they are not sure if he hit his head or lost consciousness. He remained outside for an unknown amount of time before his family could get him inside. He does not  remember much of the fall and is not able to provide details of he events before or after the fall. He notes that he had 3 drinks prior to arrival. He is complaining of some neck pain but does not admit to any other pain. EMS noted that the patient was hypotensive to the 80s systolic en route and had a brief 1 minute episode in which he went unresponsive, staring off to the left side. Patient received a second covid vaccine on 01/20/2022. Per guidelines, all hospitalization are reported.
FELT DIZZY; NOT FELT WELL AFTER VACCINATION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced felt dizzy, and not felt well after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt dizzy, and not felt well after vaccination. This report was non-serious.
I didn't have an adverse reaction until 6 days after the injection. The injection site became red and swollen and my whole body has been itching for 2 days now since 1/05/2021.
Contracted shingles a few weeks later. Did a study and found a small percentage of test subjects contracted shingles.